PubMed

Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa.

Freeman EE, White RG, Bakker R, Orroth KK, Weiss HA, Buvé A, Hayes RJ, Glynn JR.

Vaccine. 2009 Feb 5;27(6):940-6. Epub 2008 Dec 9.PMID: 19071187 [PubMed - indexed for MEDLINE]Related articlesFree article

Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?

White RG, Glynn JR, Orroth KK, Freeman EE, Bakker R, Weiss HA, Kumaranayake L, Habbema JD, Buvé A, Hayes RJ.

AIDS. 2008 Sep 12;22(14):1841-50.PMID: 18753931 [PubMed - indexed for MEDLINE]Related articles

Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy?

White RG, Orroth KK, Glynn JR, Freeman EE, Bakker R, Habbema JD, Terris-Prestholt F, Kumaranayake L, Buvé A, Hayes RJ.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):346-53.PMID: 18176323 [PubMed - indexed for MEDLINE]Related articles

Quantifying HIV-1 transmission due to contaminated injections.

White RG, Ben SC, Kedhar A, Orroth KK, Biraro S, Baggaley RF, Whitworth J, Korenromp EL, Ghani A, Boily MC, Hayes RJ.

Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9794-9. Epub 2007 May 23.PMID: 17522260 [PubMed - indexed for MEDLINE]Related articlesFree article

Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics.

Freeman EE, Orroth KK, White RG, Glynn JR, Bakker R, Boily MC, Habbema D, Buvé A, Hayes R.

Sex Transm Infect. 2007 Aug;83 Suppl 1:i17-24. Epub 2007 Apr 3. Erratum in: Sex Transm Infect. 2007 Oct;83(6):500. PMID: 17405782 [PubMed - indexed for MEDLINE]Related articles

Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study.

Orroth KK, Freeman EE, Bakker R, Buvé A, Glynn JR, Boily MC, White RG, Habbema JD, Hayes RJ.

Sex Transm Infect. 2007 Aug;83 Suppl 1:i5-16. Epub 2007 Apr 3. Erratum in: Sex Transm Infect. 2007 Oct;83(6):500. PMID: 17405781 [PubMed - indexed for MEDLINE]Related articlesFree article

Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results.

Orroth KK, White RG, Korenromp EL, Bakker R, Changalucha J, Habbema JD, Hayes RJ.

Sex Transm Dis. 2006 Sep;33(9):536-44.PMID: 16778738 [PubMed - indexed for MEDLINE]Related articles

Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study.

Todd J, Grosskurth H, Changalucha J, Obasi A, Mosha F, Balira R, Orroth K, Hugonnet S, Pujades M, Ross D, Gavyole A, Mabey D, Hayes R.

J Infect Dis. 2006 Feb 1;193(3):458-66. Epub 2005 Dec 30.PMID: 16388496 [PubMed - indexed for MEDLINE]Related articles

Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study.

White RG, Orroth KK, Korenromp EL, Bakker R, Wambura M, Sewankambo NK, Gray RH, Kamali A, Whitworth JA, Grosskurth H, Habbema JD, Hayes RJ.

J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1500-13.PMID: 15602129 [PubMed - indexed for MEDLINE]Related articles

Higher risk behaviour and rates of sexually transmitted diseases in Mwanza compared to Uganda may help explain HIV prevention trial outcomes.

Orroth KK, Korenromp EL, White RG, Gavyole A, Gray RH, Muhangi L, Sewankambo NK, Quigley M, Wawer MJ, Whitworth JA, Grosskurth H, Habbema JD, Hayes RJ.

AIDS. 2003 Dec 5;17(18):2653-60.PMID: 14685060 [PubMed - indexed for MEDLINE]Related articles